American International Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-8,301
| Closed | -$192 | – | 3197 |
|
|
2020
Q4 | $192 | Sell |
8,301
-238
| -3% | -$6 | ﹤0.01% | 2308 |
|
|
2020
Q3 | $87K | Sell |
8,539
-194
| -2% | -$1.98K | ﹤0.01% | 2602 |
|
|
2020
Q2 | $130K | Buy |
8,733
+426
| +5% | +$6.34K | ﹤0.01% | 2364 |
|
|
2020
Q1 | $101K | Buy |
8,307
+3,662
| +79% | +$44.5K | ﹤0.01% | 2300 |
|
|
2019
Q4 | $74K | Sell |
4,645
-39
| -0.8% | -$621 | ﹤0.01% | 2767 |
|
|
2019
Q3 | $58K | Buy |
+4,684
| New | +$58K | ﹤0.01% | 2858 |
|